Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022156

Expand all

CLEVIPREX (CLEVIDIPINE)
25MG/50ML (0.5MG/ML) Marketing Status: Prescription

Active Ingredient: CLEVIDIPINE
Proprietary Name: CLEVIPREX
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: 25MG/50ML (0.5MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022156
Product Number: 001
Approval Date: Aug 1, 2008
Applicant Holder Full Name: CHIESI USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLEVIPREX (CLEVIDIPINE)
50MG/100ML (0.5MG/ML) Marketing Status: Prescription

Active Ingredient: CLEVIDIPINE
Proprietary Name: CLEVIPREX
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: 50MG/100ML (0.5MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022156
Product Number: 002
Approval Date: Aug 1, 2008
Applicant Holder Full Name: CHIESI USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLEVIPREX (CLEVIDIPINE)
125MG/250ML (0.5MG/ML) Marketing Status: Discontinued

Active Ingredient: CLEVIDIPINE
Proprietary Name: CLEVIPREX
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: 125MG/250ML (0.5MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022156
Product Number: 003
Approval Date: Nov 8, 2013
Applicant Holder Full Name: CHIESI USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English